Pharma’s Upcoming Messaging Battles In US Pricing Debate Foreshadowed In CBO Report

 
• By Sarah Karlin-Smith
  
Pills in Capitol Hill forecast
The CBO report probably won't change the forecast for Rx pricing legislation, but it will definitely hang in the air.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pricing Debate

More from Market Access